Bank Of America Corp Evelo Biosciences, Inc. Transaction History

Bank Of America Corp

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.17 - $1.57 $5,362 - $49,527	31,546 Added 163.63%	50,825 $9,000
Q4 2022 Feb 10, 2023	SELL	$1.44 - $48.2 $42,374 - $1.42 Million	-29,427 Reduced 60.42%	19,279 $31,000
Q3 2022 Nov 14, 2022	BUY	$1.86 - $41.8 $38,064 - $855,437	20,465 Added 72.47%	48,706 $102,000
Q2 2022 Aug 12, 2022	BUY	$1.46 - $3.55 $17,630 - $42,869	12,076 Added 74.7%	28,241 $59,000
Q1 2022 May 16, 2022	SELL	$2.66 - $6.63 $48,207 - $120,155	-18,123 Reduced 52.86%	16,165 $55,000
Q4 2021 Feb 08, 2022	BUY	$6.07 - $12.0 $165,899 - $327,972	27,331 Added 392.86%	34,288 $208,000
Q3 2021 Nov 15, 2021	BUY	$6.79 - $13.9 $2,179 - $4,461	321 Added 4.84%	6,957 $49,000
Q2 2021 Sep 13, 2021	BUY	$9.43 - $16.6 $62,577 - $110,157	6,636 New	6,636 $91,000

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Bank Of America Corp , based on Form 13F filings with the SEC.

Stay updated on Bank Of America Corp with notifications on news.